Abstract
Purpose
To evaluate the clinical and aesthetic outcome of percutaneous injection of sclerosant agents to treat head and neck cystic malformations (HNCM) and to assess their recurrence rate based on histology and site.
Methods
Fifty-four subjects (mean age 46 years) with HNCM treated by percutaneous injection of sclerosant agents between January and December 2017 were included. Imaging and clinical data before and after the procedure were collected. Quality of Life Index, Pain Visual Analogue Scale, and Aesthetic Scale scores were measured to assess clinical and aesthetic outcomes. A size reduction of ≥ 70% assessed through the visual scale was considered significant.
Results
Of the 54 HNCM, there were 26 (48%) lymphatic malformations (LM), 13 (24%) salivary epithelial duct cysts of the parotid gland, 12 (22%) salivary mucoceles, and 3 (5%) branchial cysts. A significant size reduction and a satisfactory clinical-aesthetic outcome were observed in all types of LM. The number of reinterventions was significantly associated with the number of lesions (p < 0.001). The lowest number of interventions was observed in macrocystic lymphatic malformations (average of 1.2 interventions). All salivary epithelial duct cysts showed a significant reduction in size, a satisfactory clinical-aesthetic outcome, and an average of 1.16 interventions per patient. Mucoceles had a worse response, with only 3/14 patients showing a satisfactory and long-lasting clinical outcome (average of 1.16 interventions). Treatment of branchial cysts showed the worst outcome with a limited clinical response (3/3).
Conclusion
Percutaneous injection of sclerosant agents may be considered as a first-line treatment for LM and salivary epithelial duct cysts.
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs10006-024-01210-9/MediaObjects/10006_2024_1210_Fig1_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs10006-024-01210-9/MediaObjects/10006_2024_1210_Fig2_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs10006-024-01210-9/MediaObjects/10006_2024_1210_Fig3_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs10006-024-01210-9/MediaObjects/10006_2024_1210_Fig4_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs10006-024-01210-9/MediaObjects/10006_2024_1210_Fig5_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs10006-024-01210-9/MediaObjects/10006_2024_1210_Fig6_HTML.png)
Similar content being viewed by others
References
Zhou Q, Zheng JW, Mai HM, Luo QF, Fan XD, Su LX et al (2011) Treatment guidelines of lymphatic malformations of the head and neck. Oral Oncol 47(12):1105–1109
Vinayachandran D, Sankarapandian S (2013) Salivary duct cyst: histo-pathologic correlatioN. J Clin Imaging Sci 3(Suppl 1):3
Nallasivam KU, Sudha BR (2015) Oral mucocele: review of literature and a case report. J Pharm Bioallied Sci 7(Suppl 2):S731–S733
Coste AH, Lofgren DH, Shermetaro C (2022) Branchial cleft cyst. StatPearls, Treasure island (FL)
Gallagher JR, Martini J, Carroll S, Small A, Teng J (2022) Annual prevalence estimation of lymphatic malformation with a cutaneous component: observational study of a national representative sample of physicians. Orphanet J Rare Dis 17(1):192
Lee SY, Loll EG, Hassan AS, Cheng M, Wang A, Farmer DL (2022) Genetic and molecular determinants of lymphatic malformations: potential targets for therapy. J Dev Biol 10(1):11
Mulligan PR, Prajapati HJ, Martin LG, Patel TH (2014) Vascular anomalies: classification, imaging characteristics and implications for interventional radiology treatment approaches. Br J Radiol 87(1035):20130392
Takeda Y, Yamamoto H (2001) Salivary duct cyst: its frequency in a certain Japanese population group (Tohoku districts), with special reference to adenomatous proliferation of the epithelial lining. J Oral Sci 43(1):9–13
Stojanov IJ, Malik UA, Woo SB (2017) Intraoral salivary duct cyst: clinical and histopathologic features of 177 cases. Head Neck Pathol 11(4):469–476
Seifert G (1992) Tumour-like lesions of the salivary glands. The new WHO classification. Pathol Res Pract 188(7):836–846
Prasad SC, Azeez A, Thada ND, Rao P, Bacciu A, Prasad KC (2014) Branchial anomalies: diagnosis and management. Int J Otolaryngol 2014:237015
Patel S, Bhatt AA (2019) Thyroglossal duct pathology and mimics. Insights Imaging 10(1):12
Perkins JA, Manning SC, Tempero RM, Cunningham MJ, Edmonds JL Jr, Hoffer FA et al (2010) Lymphatic malformations: review of current treatment. Otolaryngol Head Neck Surg 142(6):795–803 e1
Legiehn GM, Heran MK (2008) Venous malformations: classification, development, diagnosis, and interventional radiologic management. Radiol Clin N Am 46(3):545–597 vi
Ha J, Yu YC, Lannigan F (2014) A review of the management of lymphangiomas. Curr Pediatr Rev 10(3):238–248
Bourgouin P, Thomas-Chausse F, Gilbert P, Giroux MF, Perigny S, Guertin L et al (2018) Effectiveness and safety of sclerotherapy for treatment of low-flow vascular malformations of the oropharyngeal region. J Vasc Interv Radiol 29(6):809–815
Lee HJ, Kim TW, Kim JM, Kim GW, Ko HC, Kim BS et al (2017) Percutaneous sclerotherapy using bleomycin for the treatment of vascular malformations. Int J Dermatol 56(11):1186–1191
Horbach SE, Lokhorst MM, Saeed P, de Gouyon Matignon de Pontouraude CM, Rothova A, van der Horst CM (2016) Sclerotherapy for low-flow vascular malformations of the head and neck: a systematic review of sclerosing agents. J Plast Reconstr Aesthet Surg 69(3):295–304
Elluru RG, Balakrishnan K, Padua HM (2014) Lymphatic malformations: diagnosis and management. Semin Pediatr Surg 23(4):178–185
Zhao XP, Huang ZQ, Chen WL, Wang YY, Lin ZY (2016) Percutaneous sclerotherapy of arteriovenous malformations of the face using fibrin glue combined with OK-432 and bleomycin after embolisation. Br J Oral Maxillofac Surg 54(2):187–191
Kim MG, Kim SG, Lee JH, Eun YG, Yeo SG (2008) The therapeutic effect of OK-432 (picibanil) sclerotherapy for benign neck cysts. Laryngoscope. 118(12):2177–2181
Burckhardt CS, Anderson KL (2003) The quality of life scale (QOLS): reliability, validity, and utilization. Health Qual Life Outcomes 1:60
Delgado DA, Lambert BS, Boutris N, McCulloch PC, Robbins AB, Moreno MR et al (2018) Validation of digital visual analog scale pain scoring with a traditional paper-based visual analog scale in adults. J Am Acad Orthop Surg Glob Res Rev 2(3):e088
Funk W, Podmelle F, Guiol C, Metelmann HR (2012) Aesthetic satisfaction scoring - introducing an aesthetic numeric analogue scale (ANA-scale). J Craniomaxillofac Surg 40(5):439–442
Malic CC, Guilfoyle R, Courtemanche RJM, Arneja JS, Heran MKS, Courtemanche DJ (2017) Lymphatic malformation architecture: implications for treatment with OK-432. J Craniofac Surg 28(7):1721–1724
Luzzatto C, Midrio P, Tchaprassian Z, Guglielmi M (2000) Sclerosing treatment of lymphangiomas with OK-432. Arch Dis Child 82(4):316–318
Merrow AC, Gupta A, Patel MN, Adams DM (2016) 2014 revised classification of vascular lesions from the international society for the study of vascular anomalies: radiologic-pathologic update. Radiographics. 36(5):1494–1516
Hancock BJ, St-Vil D, Luks FI, Di Lorenzo M, Blanchard H (1992) Complications of lymphangiomas in children. J Pediatr Surg 27(2):220–224 discussion 4-6
Gupta R, Balasubramanian D, Clark JR (2015) Salivary gland lesions: recent advances and evolving concepts. Oral Surg Oral Med Oral Pathol Oral Radiol 119(6):661–674
Bialek EJ, Jakubowski W, Zajkowski P, Szopinski KT, Osmolski A (2006) US of the major salivary glands: anatomy and spatial relationships, pathologic conditions, and pitfalls. Radiographics. 26(3):745–763
Batsakis JG, Raymond AK (1989) Sialocysts of the parotid glands. Ann Otol Rhinol Laryngol 98(6):487–489
Ogita S, Tsuto T, Nakamura K, Deguchi E, Tokiwa K, Iwai N (1996) OK-432 therapy for lymphangioma in children: why and how does it work? J Pediatr Surg 31(4):477–480
Rho MH, Kim DW, Kwon JS, Lee SW, Sung YS, Song YK et al (2006) OK-432 sclerotherapy of plunging ranula in 21 patients: it can be a substitute for surgery. AJNR Am J Neuroradiol 27(5):1090–1095
Fukase S, Ohta N, Inamura K, Aoyagi M (2003) Treatment of ranula wth intracystic injection of the streptococcal preparation OK-432. Ann Otol Rhinol Laryngol 112(3):214–220
Ha EJ, Baek SM, Baek JH, Shin SY, Han M, Kim CH (2017) Efficacy and safety of ethanol ablation for branchial cleft cysts. AJNR Am J Neuroradiol 38(12):2351–2356
Spinelli C, Rossi L, Strambi S, Piscioneri J, Natale G, Bertocchini A et al (2016) Branchial cleft and pouch anomalies in childhood: a report of 50 surgical cases. J Endocrinol Investig 39(5):529–535
Kullendorff CM (1997) Efficacy of bleomycin treatment for symptomatic hemangiomas in children. Pediatr Surg Int 12(7):526–528
Eivazi B, Werner JA (2014) Extracranial vascular malformations (hemangiomas and vascular malformations) in children and adolescents - diagnosis, clinic, and therapy. GMS Curr Top Otorhinolaryngol Head Neck Surg 13:Doc02
Author contributions
Ilaria Paladini: design, conduct, analysis, and writing; Silvia Schirò: design, conduct, analysis, writing; Roberta Eufrasia Ledda: conduct and writing; Ludovica Leo: analysis; Gianluca Milanese: conduct; Enrico Epifani: conduct; Andrea Andreone: conduct; Giulia Capurri: conduct; Matteo Fantoni: conduct; Andrea Gemignani: conduct; Alessandro Gritti: conduct; Enrico Sesenna: conduct; Roberto Menozzi: design, conduct. All authors read and approved the final manuscript.
Author information
Authors and Affiliations
Contributions
All data supporting the findings of this study are available within the paper and its Supplementary Information.
Corresponding author
Ethics declarations
Ethics approval and consent to participate
This study was approved by the Institutional Review Board of the University Hospital of Parma (Comitato Etico Emilia Romagna Nord, 323/2018/OSS/AOUPR), compliant with HIPPA. Given the retrospective nature of the study, informed consent was waived.
Consent to publish
Written informed consent for publication of their details (photographs) was obtained from the study participants.
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Paladini, I., Schirò, S., Ledda, R.E. et al. Percutaneous injection of sclerosant agents as an effective treatment for cystic malformations of the head and neck. Oral Maxillofac Surg 28, 809–818 (2024). https://doi.org/10.1007/s10006-024-01210-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10006-024-01210-9